Conclusions:
Real-time continuous glucose monitoring significantly improves A1C compared with SMBG in patients with T2DM not taking prandial insulin. This technology might benefit a wider population of people with diabetes than previously thought.
You can read an abstract at:
http://www.journalofdst.org/May2011/PDF/Abstract/VOL-5-3-ORG1-EHRHARDT-ABSTRACT.pdf
No comments :
Post a Comment